• CA-074 Me in Necroptosis: Dissecting Lysosomal Cathepsin B F

  2026-05-20

  Explore the unique power of CA-074 Me, a selective cathepsin B inhibitor, in uncovering the lysosomal mechanisms underpinning necroptosis and inflammation. This article reveals how recent mechanistic breakthroughs inform practical assay design and interpretation.

• 3-Methyladenine in Autophagy Research: Workflows & Troublesh

  2026-05-19

  3-Methyladenine (3-MA) empowers researchers with precise, temporally controlled autophagy inhibition, enabling nuanced interrogation of the PI3K signaling axis in cancer and cell migration studies. Discover protocol refinements, troubleshooting strategies, and the translational impact of cutting-edge autophagy research using APExBIO’s gold-standard reagent.

• Sunitinib: Multi-Targeted RTK Inhibitor for Cancer Research

  2026-05-19

  Sunitinib stands out as a potent multi-targeted receptor tyrosine kinase inhibitor, unlocking new depth in tumor angiogenesis and apoptosis studies. Recent research highlights its synergy with metabolic inhibitors to overcome resistance in renal cell carcinoma models, offering practical avenues for reproducible experimental setup and troubleshooting.

• hiPSC-Derived Intestinal Organoids: Precision Tools for CYP2

  2026-05-18

  This study introduces a streamlined protocol for generating human iPSC-derived intestinal organoids capable of modeling intestinal drug metabolism, specifically cytochrome P450 activity. The findings highlight the system’s potential for reliable pharmacokinetic studies, addressing key limitations of traditional models.

• Cathepsin B Inhibitor CA-074: Technical Guidance for Researc

  2026-05-18

  Cathepsin B inhibitor CA-074 (SKU A1926) enables selective, high-affinity inhibition of cathepsin B, supporting researchers in dissecting protease roles in cancer metastasis, neurotoxicity, and immune response modulation. It is best suited for in vitro and in vivo workflows requiring specificity and low cytotoxicity, but should not be used where off-target cathepsin inhibition or long-term solution stability are critical without additional validation.

• Comparative Antibacterial Activity of Cefoperazone and β-Lac

  2026-05-17

  This article reviews a landmark study comparing N-formimidoyl thienamycin (MK0787) with contemporary β-lactam antibiotics, including cefoperazone, across a range of resistant clinical isolates. The findings clarify the relative efficacy of these agents against gram-negative bacilli and highlight the role of β-lactamase stability in antimicrobial activity.

• GANT61: Precision GLI Inhibition Unlocks Tumor Microenvironm

  2026-05-16

  Explore how GANT61, a potent GLI inhibitor, redefines cancer research by enabling direct interrogation of the immunosuppressive tumor microenvironment. This article introduces a unique perspective on GANT61’s utility beyond classic pathway blockade, detailing its impact on experimental design and translational insights.

• hiPSC-Derived Intestinal Organoids Advance CYP2C19 Drug Meta

  2026-05-15

  This study introduces a robust protocol for differentiating human induced pluripotent stem cells (hiPSCs) into intestinal organoids that recapitulate mature enterocyte function, including CYP-mediated drug metabolism. The findings establish a scalable, physiologically relevant platform for pharmacokinetic studies, addressing limitations of Caco-2 and animal models.

• CRISPRi Targeting Fabp4 in Adipocytes: New Strategies for Ob

  2026-05-15

  This study introduces a targeted CRISPR interference (CRISPRi) delivery system against Fabp4 in white adipocytes, demonstrating significant reductions in obesity, inflammation, hepatic steatosis, and insulin resistance in a murine model. The findings highlight the therapeutic potential of precise adipocyte gene modulation for metabolic disorder research.

• ECL Chemiluminescent Substrate Detection Kit: Precision Prot

  2026-05-14

  The ECL Chemiluminescent Substrate Detection Kit empowers researchers with high-sensitivity HRP-based protein and nucleic acid detection, critical for both routine Western blots and advanced chemiluminescent immunoassays. Its robust performance and adaptability make it indispensable for integrated omics workflows and troubleshooting challenging targets.

• Multidimensional Ionizable Lipid Design for Organ-Selective

  2026-05-14

  This article reviews how He et al. leveraged the Ugi four-component reaction to rapidly generate a structurally diverse ionizable lipid (IL) library, enabling high-performing and organ-specific mRNA delivery in lipid nanoparticles (LNPs). The study's findings advance the rational design of LNPs for targeted mRNA therapeutics and highlight structure–property relationships essential for translation.

• RG7388 MDM2 Antagonist: Applied Workflows and Troubleshootin

  2026-05-13

  RG7388 (MDM2 antagonist, oral, selective) empowers precise p53 pathway activation and robust cancer cell apoptosis induction, especially in wild-type p53 tumor models. This guide translates the latest biomarker-driven insights and benchmarked protocols into actionable workflows, maximizing translational impact and experimental reproducibility.

• gamma-Glu-Cys: Protocol Innovations for Glutathione Research

  2026-05-13

  gamma-Glu-Cys (γ-Glu-Cys) from APExBIO unlocks precision in glutathione metabolism research and kokumi peptide engineering. This guide details optimized protocols, advanced use-cases, and troubleshooting strategies that maximize experimental yield and reproducibility.

• ML-7 Hydrochloride: In-Depth Mechanistic Insights for MLCK P

  2026-05-12

  Explore the advanced mechanism of ML-7 hydrochloride as a potent myosin light chain kinase inhibitor, with novel insights into its precise regulation of cellular contractility and implications for translational research. This article provides a unique, evidence-driven perspective for researchers seeking to optimize MLCK pathway assays.

• Rapamycin (Sirolimus) in mTOR Pathways: Protocols & Solution

  2026-05-12

  Rapamycin (Sirolimus) stands at the forefront of mTOR pathway research, enabling precise dissection of cell growth, metabolism, and survival mechanisms across cancer and immunology. This article delivers actionable protocols, advanced applications, and troubleshooting insights, drawing on landmark studies to optimize your experimental outcomes.

15636 records 1/1043 page Next 12345 下5页 Last page